JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study
Fecha de publicación
2015Título de revista
Journal Of Clinical Oncology
Tipo de contenido
Publicación de congreso